From: The role of androgens in experimental rodent mammary carcinogenesis
Reference | Animal model | Type of androgen | Dose a | Duration | Incidence |
---|---|---|---|---|---|
7,12-Dimethylbenz(a)anthracene | Â | Â | Â | Â | |
Briziarelli [40] | SD ratsb | TP | 0.01, 0.05, 0.5, 1 or 1.5?mg daily | 30?days | ? (at doses of 0.5 to 1.5?mg)c |
Briziarelli [41] | SD rats | TP | 0.13, 0.26, 0.4 or 10.5?mg daily | 10?days | ? (0.26 only) |
Li and colleagues [42] | SD rats | DHEA | (Not described) | Implant | ? |
Luo and colleagues [43] | SD rats | DHEA | 5, 10 or 20?mg daily | 9?months | ? |
Kohama and colleagues [44] | Wistar rats | DHEA or TE | 150?mg/kg DHEA or 60?mg/kg TE weekly | 22?weeks | ? |
Methylcholanthrene | Â | Â | Â | Â | Â |
Shay and colleagues [15] | Wistar rats | T | 37 or 75?mg | Implant | ? |
Shay and colleagues [45] | Wistar rats | T | 75?mg | Implant | ? |
N -Nitroso- N -methylurea | Â | Â | Â | Â | Â |
Lubet and colleagues [46] | SD rats | DHEA | 5, 24, 120, 600 or 2,000?mg/kg DHEA in diet | 109?days | ? (600/2,000) |